Medicine and Dentistry
Dermatology
100%
Melanoma
86%
Mohs Surgery
83%
Hydroxylapatite
80%
Biopsy Technique
75%
Pigmented Lesion
68%
Skin Defect
66%
Restylane
66%
Cosmetics
61%
Neoplasm
52%
Diagnosis
45%
Skin Type
44%
Skin Carcinoma
37%
Health Care Cost
37%
Actinic Keratosis
33%
Nasolabial Fold
33%
Corynebacterium jeikeium
33%
Adult Onset Still Disease
33%
Tinea Capitis
33%
Low Level Laser Therapy
33%
Dermatoscopy
33%
Medicare
33%
Patient Satisfaction
33%
Gene Expression
33%
Carcinosis
33%
Wound
33%
Transplantation
33%
Pseudoxanthoma Elasticum
33%
Placebo
33%
Phosphate Binder
33%
Randomized Controlled Trial
33%
Sepsis
33%
Radiation Therapy
33%
Dermatological Agent
33%
Burnout
33%
Erythema
33%
Scalp
30%
Sevelamer
28%
Cross-Link
26%
Skin Water Loss
26%
Ceramide
26%
Basal-Cell Carcinoma
25%
Hyperpigmentation
25%
Clinician
24%
Papular Rash
22%
Health Care
22%
Prevalence
22%
Squamous Cell Carcinoma
20%
Skin Disease
19%
Infection
17%
Keyphrases
Mohs Micrographic Surgery
100%
Pigmented Lesions
69%
Atopic Dermatitis
66%
Multispectral Digital Skin Lesion Analysis
66%
Calcium Hydroxylapatite
66%
Dermatologist
64%
Artificial Intelligence
50%
Melanoma
47%
Mount Sinai
41%
Medical Center
41%
Confidence Interval
38%
Cutaneous Squamous Cell Carcinoma (cSCC)
37%
Melanoma in Situ
35%
Invasive Melanoma
35%
International Dermatology Outcome Measures
33%
Gene Expression Profile
33%
Actinic Keratosis
33%
Medicare Eligible
33%
Predictive Probability
33%
Thymic Stromal Lymphopoietin
33%
Health Care Costs
33%
Corynebacterium Jeikeium
33%
Black Dot
33%
High Risk
33%
Adjuvant Radiation Therapy
33%
Tinea Capitis
33%
Gaps in Care
33%
Therapy Decision
33%
Utilization Pattern
33%
Immunosuppressed
33%
High-resolution Ultrasound
33%
Laser Therapy
33%
Sevelamer Hydrochloride
33%
Gaps in Research
33%
Stakeholder Survey
33%
Protein Allergens
33%
Probability Model
33%
Phosphate Binder
33%
Fitzpatrick Skin Type
33%
Ovalbumin
33%
Nasolabial Fold
33%
Melanocytic Lesions
33%
Pseudoxanthoma Elasticum
33%
Organ Transplant Patient
33%
Randomized Controlled Trial
33%
Dermoscopy
33%
Carcinomatosis
33%
Cutaneous Manifestations
33%
Cost-benefit Analysis
33%
Rosaceae
33%
